Pharmacokinetics of 125I-labelled IgG, F(ab′)2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use

This publication has 9 references indexed in Scilit:

• Pharmacokinetics of 125I-labelled Walterinnesia aegyptia venom and its specific antivenins: flash absorption and distribution of the venom and its toxin versus slow absorption and distribution of IgG, F(ab′)2 and F(ab) of the antivenin
  Toxicon, 1998
• A three-compartment open pharmacokinetic model can explain variable toxicities of cobra venoms and their alpha toxins
  Toxicon, 1996
• Androctonus crassicauda (Olivier), a dangerous and unduly neglected scorpion—I. Pharmacological and clinical studies
  Toxicon, 1994
• Experimental treatment protocols for scorpion envenomation: A review of common therapies and an effect of kallikrein-kinin inhibitors
  Toxicon, 1992
• Do changes in body temperature following envenomation by the scorpion Leiurus quinquestriatus influence the course of toxicity?
  Toxicon, 1990
• Are the toxicological effects of scorpion envenomation related to tissue venom concentration?
  Toxicon, 1988
• Pharmacokinetics of 125I-labelled antivenin to the venom from the scorpion Androctonus amoreuxi
  Toxicon, 1983
• Pharmacokinetics of 125I-labelled venom from the scorpion Androctonus amoreuxi, Aud. and Sav.
  Toxicon, 1980
• Poisoning by Scorpion Stings in Israel
  The American Journal of Tropical Medicine, 1949